Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $39.22 Million |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $- |
| Beta | 0 |
| Outstanding Shares | - |
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Thematic tracking ETN issued by UBS AG, London Branch, that tracks the Bloomberg Transatlantic Top50 Biotech Net Return Index EUR, giving exposure to large US and European biotechnology companies. It is listed on the JSE, denominated in South African rand and expires on 27 June 2028.